14.1 Venipuncture & Pharmaceutical Agents

14.1 Venipuncture & Pharmaceutical Agents

Quick Answer: Canadian RTRs perform venipuncture and administer ordered pharmaceuticals (including IV contrast) only within provincial regulation, employer policy, documented competency, and the requisition. Master aseptic technique, site selection, route verification, and recognition of infiltration, extravasation, and phlebitis. Know emergency drugs (epinephrine, antihistamines, bronchodilators) for recognition and team response—administration occurs only under authorized protocol/order, not by independent prescribing.

RTR.5 Administer substances sits inside the large Clinical Expert band shared with RTR.6 (27–32% combined on the May 2024 Radiological Technology blueprint). Expect application items that mix access technique, drug safety, contrast physics, and emergency judgment—not isolated recall of brand names.

Scope: What “Administer” Means for an RTR

Entry-to-practice RTRs prepare and administer substances within their scope when:

1. There is a valid medical order (or standing order/protocol approved by the organization).
2. The agent, dose/volume, route, and timing match policy and the order.
3. The technologist has current competency for that skill (venipuncture, power-injector setup, oral/rectal contrast, etc.).
4. Screening (allergies, renal risk, pregnancy when relevant, concurrent meds such as metformin flags) is complete or escalated.
5. Documentation and handoff requirements of the facility are met.

Do not invent expanded prescribing rights. The RTR does not independently select and prescribe new drug therapy. You may initiate or continue protocol-defined steps (e.g., inject ordered contrast, hold injection for safety concerns, call the radiologist/physician, assist the code team). Provincial medical radiation technologist legislation, controlled-acts frameworks, and hospital medical directives define the exact envelope—facility policy always governs day-to-day practice.

Routes you must understand (RTR.5.2–5.4)

Wrong-route errors (especially intrathecal injection of the wrong contrast formulation) are never-events. If packaging, label, or pathway looks wrong—stop and verify with the radiologist/pharmacist pathway before anything enters a needle.

Venipuncture (RTR.5.1)

Preparation

• Confirm identity (two identifiers), order, laterality/side if relevant, and allergies.
• Explain the procedure; obtain cooperation and position the limb comfortably.
• Perform hand hygiene; assemble sterile or single-use supplies per protocol (tourniquet, antiseptic, cannula/catheter of appropriate gauge, extension set, saline flush, dressings, sharps container).
• For contrast CT, plan access that supports the required flow rate (often larger-gauge antecubital access for high-rate multiphase CT—follow departmental power-injector guidelines).

Aseptic technique essentials

• Cleanse the site with the approved antiseptic; allow dry time (especially alcohol-based products).
• Do not re-palpate the cleansed site with a non-sterile finger unless you re-cleanse.
• Maintain a no-touch pathway from hub to flush; secure the cannula immediately after flashback/confirmation.
• Dispose of sharps at the point of use; never recap used needles with two-handed technique.

Site selection

Prefer upper extremity veins in this general order of practicality when suitable:

1. Median cubital, cephalic, and basilic veins in the antecubital fossa (good calibre for many power injections when policy allows).
2. Forearm veins when antecubital sites are exhausted or reserved.
3. Avoid, when possible: sites distal to prior failed sticks on the same attempt session, areas of infection/cellulitis, severe edema, arteriovenous fistula/graft arms (dialysis access—never use without explicit vascular-access direction), and limbs with ipsilateral mastectomy/lymph-node dissection if facility policy restricts them.

Hand veins may be used for lower-rate infusions but are often suboptimal for high-pressure power injection—follow injector and vendor guidance; many departments require antecubital or large-forearm access above a stated mL/s threshold.

Confirmation of patency

Before contrast:

• Aspirate or observe free blood return if policy uses that check.
• Flush with saline; the flush should run without resistance, pain, or swelling.
• Observe the site throughout the test injection and the full contrast bolus.
• Educate the patient to report burning, tightness, or sharp pain immediately.

Complications of IV Access

Extravasation of iodinated contrast is both a clinical and a quality/risk event. Large volumes in a closed compartment can threaten limb perfusion. Do not minimize patient reports of pain during injection—stop and assess.

Pharmaceutical Agents in the Imaging Environment

Local anesthetics — awareness

Local anesthetics (e.g., lidocaine) may be used for invasive procedures (joint injections, some biopsies) under physician direction. As an RTR you should:

• Know that amide local anesthetics can cause rare systemic toxicity (perioral numbness, tinnitus, seizures, cardiovascular collapse) if large intravascular doses occur—recognize and call for help.
• Understand who draws and injects local anesthetic in your facility (often the physician or authorized provider).
• Support sterile field, labeling, and timeout culture so the correct agent and concentration are used.

Emergency drug recognition (technologist response vs administer)

Imaging suites stock emergency medications as part of crash-cart or contrast-reaction kits. At entry level you must recognize common agents and your role:

Exam principle: distinguishing recognition and first response from independent drug selection is high-yield. If an item asks what the technologist does first in anaphylaxis, the answer is usually stop the contrast, call for help, support ABCs, not “choose a custom polypharmacy cocktail.”

IV access specifically for contrast

• Match gauge and site to protocol flow rate and viscosity (warmed contrast often flows better—follow manufacturer/department practice).
• Use power injectors only with compatible, secured IV catheters rated for the pressure/flow; never power-inject through a questionable peripheral site.
• Keep the injection site visible (or continuously monitored) during bolus delivery when workflow allows.
• Know maximum pressures and air-detection features of the injector; prime tubing carefully to avoid air embolism risk.

Safe Workflow Checklist (Integrating RTR.5.1–5.4)

1. Verify order, identity, allergies, and relevant labs/flags (e.g., eGFR when IV iodinated contrast is planned—detail in Section 14.2).
2. Select route and agent that match the order and contraindications.
3. Obtain and secure access with aseptic technique; confirm patency.
4. Explain sensations (warmth, metallic taste are common with IV iodinated contrast) versus warning symptoms (pain at site, difficulty breathing, throat tightness).
5. Administer only as authorized; monitor continuously during and immediately after injection.
6. If complication or reaction—stop, assess, call for help, treat within protocol, document, arrange follow-up imaging or clinical review as directed.

Common Exam Traps

1. Treating the RTR as an independent prescriber of epinephrine regimens without protocol language.
2. Continuing a painful injection “to finish the scan” during likely extravasation.
3. Using a dialysis fistula arm as a convenient power-injection site.
4. Confusing infiltration language with extravasation of contrast (both require stop/assess; contrast extravasation has specific protocols and often larger tissue-risk concerns).
5. Ignoring dry time on antiseptic or re-contaminating the site.
6. Assuming hand veins are always adequate for high-rate multiphase CT.

Master venipuncture and pharmaceutical judgment as safety competencies: the image is worthless if access technique harms the patient or the wrong agent travels the wrong route.